Borracci Raúl A, Rubio Miguel, Celano Leonardo, Ingino Carlos A, Allende Norberto G, Ahuad Guerrero Rodolfo A
Hospital de Clínicas, School of Medicine, Buenos Aires University, Buenos Aires, Argentina.
Interact Cardiovasc Thorac Surg. 2014 May;18(5):539-43. doi: 10.1093/icvts/ivt550. Epub 2014 Feb 2.
The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) is an updated version of the original EuroSCORE that must be extensively validated. The objective was to prospectively evaluate the efficacy of EuroSCORE II in predicting the immediate results of cardiac surgery in Argentinean centres.
A prospective consecutive series of 503 adults who underwent cardiac surgery between January 2012 and April 2013 was studied. EuroSCORE II discrimination and accuracy were assessed in the overall cohort and in two surgically defined subgroups: isolated coronary artery bypass graft (CABG) surgery and non-CABG surgery. Additionally, a risk-adjusted cumulative sum control chart analysis was performed.
In-hospital overall mortality rate was 4.17%, while the mortality rate predicted by the EuroSCORE II was 3.18% (P = 0.402). Receiver operating characteristic curve analysis demonstrated a good overall (area 0.856) and non-CABG subgroup (area 0.857) discrimination (P = 0.0001), while discrimination in the CABG subgroup was poorer (area 0.794, P = 0.014). The model showed good calibration in predicting in-hospital mortality, both overall (Hosmer-Lemeshow, P = 0.082) and for each subgroup (non-CABG, P = 0.308, and CABG, P = 0.150).
EuroSCORE II reflects a better current surgical performance and offers a new quality standard to evaluate local outcomes. EuroSCORE showed an overall good discriminative capacity and calibration in this local population; nevertheless, the model performed optimally in non-CABG surgery and in highest-risk patients, underestimating in-hospital mortality in lowest-risk cases. The latter finding may be interpreted as an inadequate behaviour of the model, as a poor performance of surgeons or both. Larger prospective studies will elucidate this hypothesis.
欧洲心脏手术风险评估系统II(EuroSCORE II)是原始EuroSCORE的更新版本,必须进行广泛验证。目的是前瞻性评估EuroSCORE II在预测阿根廷各中心心脏手术近期结果方面的有效性。
对2012年1月至2013年4月期间接受心脏手术的503例成年患者进行前瞻性连续研究。在整个队列以及两个手术定义的亚组中评估EuroSCORE II的辨别力和准确性:单纯冠状动脉旁路移植术(CABG)手术和非CABG手术。此外,还进行了风险调整累积和控制图分析。
住院总死亡率为4.17%,而EuroSCORE II预测的死亡率为3.18%(P = 0.402)。受试者工作特征曲线分析显示整体辨别力良好(曲线下面积0.856),非CABG亚组辨别力良好(曲线下面积0.857)(P = 0.0001),而CABG亚组的辨别力较差(曲线下面积0.794,P = 0.014)。该模型在预测住院死亡率方面显示出良好的校准,整体(Hosmer-Lemeshow检验,P = 0.082)以及每个亚组(非CABG,P = 0.308,CABG,P = 0.150)均如此。
EuroSCORE II反映了当前更好的手术表现,并为评估当地手术结果提供了新的质量标准。在该当地人群中,EuroSCORE显示出整体良好的辨别力和校准;然而,该模型在非CABG手术和高危患者中表现最佳,在低风险病例中低估了住院死亡率。后一发现可能被解释为模型表现不佳、外科医生手术操作不佳或两者兼而有之。更大规模的前瞻性研究将阐明这一假设。